\[ \large\mathcal{YiHsin}\;\mathcal{Sam}\;\mathcal{Lu} \]


【Summary】 Patients increasing:

  • Increasing “all levels” (e.g. Gender)
  • Increasing “one level” (e.g. Cell type)
  • “Yes>No” to “No>Yes” (e.g. Mortality)

N


1 Variables


ECOG

  • 0 無症狀
  • 1 有症狀,可步行對生活不影響
  • 2 躺在床上時間小於50%
  • 3 躺在床上時間大於50%
  • 4 完全臥床

Gender


Age


BMI

  • 1 Normal: \(\leq25\)
  • Overweight: \(>25\)

Cell Type

  • 1 Urothelial
  • 2 Squamous
  • 3 Small cell
  • 4 Adenocarcinoma
  • 5 UC with variants (Squamous cell, glandular, sarcomatous, micro papillary, neuroendocrine, lymphoepithelial)
  • 6 Others

Side

  • 1 Left
  • 2 Right
  • 3 Both

Location

  • 0 Non-visible
  • 1 Renal pelvis
  • 2 Ureter
  • 3 Bladder cuff
  • 4 Multiple locations

Multiple


Size


Biopsy Method


pT Stage


Bladder Cancer


CIS


LVI


Surgical Margin


Pre-operative Hydronephrosis


Tumor Necrosis


Chemotherapy (UTUC)


Chemotherapy Type (UTUC)


Chemotherapy Prescription (UTUC)


Radiation Therapy


Radiation Therapy Type


Surgery Method


NxUx Method


NxUx Access


Endoscopic Method


Segmental Method


Segmental Access


Bladder Cuff Resection


Simultaneously Ipsilateral Adrenalectomy


Post_operation Intravesical C/T Instillation


2 Outcomes


Clavien Dindo Classification


Mortality


Disease Free


Cancer Specific


Bladder Free